ALLO | Allogene Therapeutics Inc.
Category: Consumer goods
Quick infos Headquarters: South San Francisco, California, United States Trade prices Volume: Market Cap: 1.65B Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: No Dividends Next ER: February 23, 2023
Earnings History Date EPS / Forecast Revenue / Forecast May 10, 2023 February 23, 2023 - / -0.6958- / 60.64KNovember 2, 2022 -0.58 / -0.644349K / 7.17KBeat! August 9, 2022 -0.52 / -0.606386K / 12.39KBeat! May 4, 2022 -0.56 / -0.578861K / 8.33KBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 9, 2022 15.02 15.60 16.04
14.89
1.57M -5.89% Aug 8, 2022 15.96 15.37 16.08
15.37
2.12M 3.23% Aug 5, 2022 15.46 14.36 15.48
14.16
1.59M 5.03% Aug 4, 2022 14.72 13.63 14.95
13.53
2.12M 8.08% Aug 3, 2022 13.62 12.77 13.97
12.77
1.57M 8.87% Aug 2, 2022 12.51 11.97 12.60
11.88
1.30M 3.22% Aug 1, 2022 12.12 12.82 12.93
12.01
1.71M -6.63% Jul 29, 2022 12.98 13.13 13.30
12.63
1.02M -2.04% Jul 28, 2022 13.25 13.93 14.02
12.39
1.08M -5.36% Jul 27, 2022 14.00 13.65 14.16
13.50
1.06M 3.32% view more
ALLO
More profiles and info about the company News
Moderna (MRNA) Reports 2023 Business View & Pipeline Updates finance.yahoo.com Jan 25, 2023 11:55 am
Arvinas, Inc. (ARVN) Soars 10.3%: Is Further Upside Left in the Stock? finance.yahoo.com Jan 25, 2023 8:35 am
Allogene Therapeutics Publishes Preclinical Data in Clinical Cancer Research Supporting DLL3 as a Potential AlloCAR T Target for Small Cell Lung Cancer finance.yahoo.com Jan 25, 2023 8:30 am Allogene stock rises ~15% as JPMorgan upgrades on near-term catalysts seekingalpha.com Jan 25, 2023 12:53 am
Allogene Therapeutics Announces Publication in Nature Medicine of Data from its Phase 1 UNIVERSAL Study of ALLO-715 for the Treatment of Relapsed/Refractory Multiple Myeloma finance.yahoo.com Jan 24, 2023 8:30 am
Is Immunocore (IMCR) Stock Outpacing Its Medical Peers This Year? finance.yahoo.com Jan 19, 2023 9:40 am
Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences finance.yahoo.com Jan 17, 2023 4:05 pm Meme traders are battling shorts again - watch these stocks seekingalpha.com Jan 14, 2023 10:46 pm
Aprea (APRE) Rises on Advancing Lead Drug to Clinical Studies finance.yahoo.com Jan 12, 2023 9:56 am Allogene Therapeutics up 7% following upgrade from Baird seekingalpha.com Jan 7, 2023 2:31 am
FDA Accepts AstraZeneca (AZN), Sanofi's RSV Antibody BLA finance.yahoo.com Jan 6, 2023 1:50 pm
Allogene Therapeutics Reports Third Quarter 2022 Financial Results and Announces Investor R&D Showcase finance.yahoo.com Jan 4, 2023 4:02 pm
Allogene Therapeutics Announces Poster Presentation of Its Phase 1 UNIVERSAL Trial in Multiple Myeloma at the 64th Annual Meeting of the American Society of Hematology finance.yahoo.com Jan 4, 2023 9:04 am
Allogene Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference finance.yahoo.com Jan 4, 2023 8:30 am Allogene ends winning streak as R&D chief departs seekingalpha.com Jan 4, 2023 1:01 am Allogene down 11% following downgrade to underperform at BofA seekingalpha.com Dec 13, 2022 1:34 am
Allogene Appoints Zachary J. Roberts, M.D., Ph.D. as Executive Vice President of Research & Development finance.yahoo.com Jan 3, 2023 8:00 am
Down -41.38% in 4 Weeks, Here's Why Allogene Therapeutics (ALLO) Looks Ripe for a Turnaround finance.yahoo.com Dec 29, 2022 9:35 am
15 Most Shorted Stocks Hedge Funds Are Buying finance.yahoo.com Dec 28, 2022 12:32 pm
Allogene Therapeutics Reports Second Quarter 2022 Financial Results finance.yahoo.com Dec 13, 2022 4:02 pm This company doesn't provide a dividend.
Talk about Allogene Therapeutics Inc. below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
